Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Condition: Chronic Heart Failure (CHF) · Sponsor: Novartis Pharmaceuticals
About this study
This study was a multi-center, randomized, double-blind, parallel group, active comparator trial designed to evaluate the overall effect of LCZ696 compared to valsartan on cognitive function as assessed by the CogState comprehensive cognitive battery in patients with Heart failure and preserved ejection fraction (HFpEF).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (135)
| Novartis Investigative Site | Andalusia, Alabama, United States | — |
| Novartis Investigative Site | Glendale, Arizona, United States | — |
| Novartis Investigative Site | Mesa, Arizona, United States | — |
| Novartis Investigative Site | Phoenix, Arizona, United States | — |
| Novartis Investigative Site | Sun City West, Arizona, United States | — |
| Novartis Investigative Site | Tucson, Arizona, United States | — |
| Novartis Investigative Site | Beverly Hills, California, United States | — |
| Novartis Investigative Site | Fresno, California, United States | — |
| Novartis Investigative Site | Loma Linda, California, United States | — |
| Novartis Investigative Site | Long Beach, California, United States | — |
| Novartis Investigative Site | Newport Beach, California, United States | — |
| Novartis Investigative Site | Santa Ana, California, United States | — |
+ 123 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02884206